Polatuzumab Vedotin in Combination With Chemotherapy in Subjects With Richter's Transformation
Polatuzumab Vedotin in Combination With Chemotherapy in Subjects With Richter's Transformation
Active, not recruiting · NCT04679012 · Registry updated 2026-09-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Polatuzumab Vedotin in Combination With Chemotherapy in Subjects With Richter's Transformation | B-cell chronic lymphocytic leukemia, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, B-Cell, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Richter transformation, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Active, not recruiting | Phase 2 | 2026-09-25 | NCT04679012 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Genentech, Inc. | 221 |
| Weill Medical College of Cornell University | 276 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Columbia University Medical center | New York | United States | 224 |
| Mount Sinai- Icahn School of Medicine | New York | United States | 1 |
| Ohio State University | Columbus | United States | 169 |
| Weill Cornell Medicine | New York | United States | 122 |